Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Graefe's Archive for Clinical and Experimental Ophthalmology
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 5/2017

01-05-2017 | Letter to the Editor (by invitation)

Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion

Authors: Gesine B. Szurman, Carsten H. Meyer, Nicolas Feltgen, Amelie Pielen, Bernhard Spitzer, Matus Rehak, Georg Spital, Spyridon Dimopoulos, Peter Szurman, Kai Januschowski, Bevacizumab Study Group Venous Occlusion

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 5/2017

Login to get access

Excerpt

Dear Editor …
Literature
1.
Januschowski K, Dimopoulos S, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Bevacizumab Study Group Venous Occlusion, Meyer CH, Szurman GB (2015) Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicenter study. Acta Ophthalmol 93:e400–e402CrossRefPubMed
2.
Szurman GB, Januschowski K, Szurman P, Feltgen N, Spitzer B, Pielen A, Rehak M, Spital G, Dimopoulos S, Bevacizumab Study Group Venous Occlusion, Meyer CH (2016) Injection scheme for intravitreal bevacizumab therapy for macular oedema due to central retinal vein occlusion: results of a multicentre study. Acta Ophthalmol [Epub ahead of print]. doi:10.​1111/​aos.​12976
3.
Januschowski K, Feltgen N, Pielen A, Spitzer B, Rehak M, Spital G, Dimopoulos S, Bevacizumab Study Group Venous Occlusion, Meyer CH, Szurman GB (2016) Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol. doi:10.​1007/​s00417-016-3471-22016
4.
Epstein DL, Algvere PV, von Wendt G et al (2012) Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study. Ophthalmology 119:2587–2591CrossRefPubMed
Metadata
Title
Predictive factors for functional improvement following intravitreal bevacizumab injections after central retinal vein occlusion
Authors
Gesine B. Szurman
Carsten H. Meyer
Nicolas Feltgen
Amelie Pielen
Bernhard Spitzer
Matus Rehak
Georg Spital
Spyridon Dimopoulos
Peter Szurman
Kai Januschowski
Bevacizumab Study Group Venous Occlusion
Publication date
01-05-2017
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 5/2017
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-017-3618-9

Other articles of this Issue 5/2017

Graefe's Archive for Clinical and Experimental Ophthalmology 5/2017 Go to the issue

Cataract

Evaluating relaxed ciliary muscle tone in presbyopic eyes

Trauma

Ocular Trauma Score as prognostic value in traumatic ocular injuries due to rotating wire brushes

Erratum

Erratum to: Role of oxidative stress in epigenetic modification of MMP-9 promoter in the development of diabetic retinopathy

Letter to the Editor

Re: Internal limiting membrane (ILM) transplantation for unclosed and large macular holes (MH)

Review Article

Microbial flora and resistance in ophthalmology: a review

Book Review

Basic Sciences in Ophthalmology, Physics and Chemistry. Authors: Flammer Josef, Mozaffarieh Maneli, Bebie Hans (2013) ISBN 978-3642-322-600 Springer